This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: U3 Pharma Gmbh. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Tomoko Takayama: Innovator in Monoclonal Antibodies
Introduction
Tomoko Takayama is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies. Her work focuses on innovative solutions that have the potential to impact therapeutic applications.
Latest Patents
Tomoko holds a patent for "Humanized AXL antibodies." This invention refers to monoclonal humanized antibodies that bind to the extracellular domain of the AXL receptor tyrosine kinase and partially inhibit AXL activity. This advancement is crucial for developing targeted therapies in various medical conditions.
Career Highlights
Tomoko is associated with U3 Pharma GmbH, where she continues to push the boundaries of research and development in her field. Her expertise in antibody engineering has positioned her as a key player in the biotechnology sector.
Collaborations
Tomoko has collaborated with notable colleagues, including Peter Wirtz and Jens Ruhe. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Tomoko Takayama's contributions to the field of monoclonal antibodies exemplify her dedication to advancing medical science. Her innovative work continues to pave the way for future breakthroughs in biotechnology.